COMMUNIQUÉS West-GlobeNewswire

IBA signe un contrat avec l’AIEA pour l'installation d'un Cyclone® KEY au Bénin, en Afrique de l'Ouest
29/02/2024
Ce contrat avec l’AIEA démontre l'accessibilité du Cyclone ® KEY pour les pays à revenu faible et intermédiaire Louvain-la-Neuve, Belgique, le 29 février, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), le leader [...]
U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®
29/02/2024
U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ ® Recommendation for use in travelers and laboratory workers follows U.S. Food and Drug Administration (FDA) approval [...]
Le Comité consultatif sur la vaccination aux États-Unis (ACIP) recommande l’utilisation d’IXCHIQ®, le vaccin à injection unique contre le chikungunya de Valneva
29/02/2024
Le Comité consultatif sur la vaccination aux États-Unis (ACIP) recommande l’utilisation d’IXCHIQ ® , le vaccin à injection unique contre le chikungunya de Valneva La recommandation pour l’utilisation chez les voyageurs [...]
BioSenic S.A. : Information on the total number of voting rights and shares
29/02/2024
PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 29 February 2024, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and [...]
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions
29/02/2024
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 29 février 2024 à 07h00 CEST – BIOSENIC (Euronext Bruxelles et Paris: BIOS), la société en phase clinique spécialisée dans les maladies [...]
Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs
29/02/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Sandoz US to pay USD 265 million in exchange for full release of all claims by the class Resolves all federal antitrust damages for [...]
CARBIOS and Landbell Group join forces to increase circularity of PET waste at first biorecycling plant
29/02/2024
CARBIOS and Landbell Group join forces to increase circularity of PET waste at first biorecycling plant CARBIOS and Landbell Group sign agreement to develop and implement solutions for the sorting, preparation and [...]
CARBIOS et Landbell Group s’unissent pour accroître la circularité des déchets PET dans la première usine de biorecyclage
29/02/2024
CARBIOS et Landbell Group s’unissent pour accroître la circularité des déchets PET dans la première usine de biorecyclage CARBIOS et Landbell Group signent un accord pour le développement et la mise en œuvre de [...]
Arcutis Announces Pricing of $150 Million Public Offering
29/02/2024
WESTLAKE VILLAGE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Tilray fait le point sur la législation internationale concernant le cannabis suite à la légalisation historique du cannabis par l’Allemagne
29/02/2024
La déclassification du cannabis en Allemagne ouvre la voie à de nouvelles opportunités commerciales pour Tilray sur ce marché médical pouvant représenter jusqu’à 3 milliards de dollars Le marché du cannabis médical au [...]
Sotera Health Announces Pricing of Secondary Offering
29/02/2024
CLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value [...]
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
29/02/2024
Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022 Achieved Record Fourth Quarter 2023 Total Revenues of $110.6 Million, an 82.0% Increase Compared to Fourth Quarter 2022 Reported [...]
Mesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023
28/02/2024
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an operational update and reported financial [...]
Opthea Reports Half-Year Financial Results and Business Updates
28/02/2024
Enrollment completion of sozinibercept Phase 3 program for wet AMD expected in calendar year (CY) Q2 2024 with top-line data mid-CY 2025 Expanded U.S. leadership team with the appointments of Dr. Frederic Guerard as CEO [...]
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
28/02/2024
Company focused on adenosine platform clinical development WESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the “Company”), a clinical-stage immuno-oncology company [...]
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
28/02/2024
FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth [...]
atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
28/02/2024
NEW YORK and BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced [...]
Astra Plastic Surgery opens surgery center in Alpharetta
28/02/2024
Consolidation of services to enhance patient experience and provide access to state-of-the-art equipment ATLANTA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Astra Plastic Surgery, an acclaimed North Georgia-based cosmetic and [...]
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
28/02/2024
SOLANA BEACH, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine [...]

Pages